Compound information
- Natural Products
- ZC1036362
- Molecular Formula
- C16H23FN2O5S
- Molecular Weight
- 374.131171056 g/mol
- Structure
-
- IUPAC Name
- tert-butyl 4-(3-fluoro-4-methoxy-phenyl)sulfonylpiperazine-1-carboxylate
- InChI
- InChI=1S/C16H23FN2O5S/c1-16(2,3)24-15(20)18-7-9-19(10-8-18)25(21,22)12-5-6-14(23-4)13(17)11-12/h5-6,11H,7-10H2,1-4H3
- InChI Key
- KALZNPRGYXGWEA-UHFFFAOYSA-N
- SMILES
- COc1ccc(S(=O)(=O)N2CCN(C(=O)OC(C)(C)C)CC2)cc1F
- Source
- ZINC000030329514
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 25 | Ring Count | 2 |
Heteroatom Count | 9 | Rotatable Bond Count | 3 |
Hydrogen Bond Acceptor Count | 5 | Hydrogen Bond Donor Count | 0 |
Topological Polar Surface Area | 76.15 Å2 | LogP | 2.623 |
LogS | -3.623 | LogD | 3.327 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.058 | Pgp substrate | 0.014 |
HIA | 0.97 | F20 % | 0.966 |
F30 % | 0.946 | Caco-2 | -4.416 |
MDCK | -4.906 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.818 | PPB | 92.765 |
VD | 2.156 | Fu | 0.561 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.325 | CYP1A2 substrate | 0.456 |
CYP2A6 substrate | 0.577 | CYP2B6 substrate | 0.651 |
CYP2C19 inhibitor | 0.912 | CYP2C19 substrate | 0.746 |
CYP2C8 substrate | 0.649 | CYP2C9 inhibitor | 0.257 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.017 |
CYP2D6 substrate | 0.697 | CYP2E1 substrate | 0.815 |
CYP3A4 inhibitor | 0.154 | CYP3A4 substrate | 0.999 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.426 | CL | 7.405 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.855 | Hepatotoxicity | 0.996 |
Mutagenicity | 0.336 | Rat Oral Acute Toxicity | 0.289 |
FDAMDD | 0.049 | Skin Sensitization | 0.0 |
Carcinogenicity | 0.941 | Eye Corrosion | 0.007 |
Eye Irritation | 0.006 | Respiratory Toxicity | 0.676 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.606 | IGC50 | 3.493 |
LC50FM | 2.061 | LC50DM | 2.49 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.408 | NR-AR-LBD | 0.283 |
NR-AhR | 0.039 | NR-Aromatase | 0.323 |
NR-ER | 0.267 | NR-ER-LBD | 0.417 |
NR-PPAR-gamma | 0.116 | SR-ARE | 0.719 |
SR-ATAD5 | 0.382 | SR-HSE | 0.057 |
SR-MMP | 0.026 | SR-p53 | 0.028 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.